Finance

Lists
Why is 300558 down 3.70%?
Dive Deeper
300558:SHE
Betta Pharmaceuticals Co Ltd
CNยฅ43.25
-3.70%
(-1.66) 1D
Nov 17, 3:04:58โ€ฏPM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300558...
Open
CNยฅ44.47
High
CNยฅ44.71
Low
CNยฅ43.00
Mkt. cap
19.01B
Avg. vol.
11.11M
Volume
6.62M
Dividend
0.35%
Quarterly dividend
CNยฅ0.04
Ex-dividend date
Jun 9, 2026
P/E ratio
68.13
52-wk high
CNยฅ78.18
52-wk low
CNยฅ38.20
EPS
CNยฅ0.63
Shares outstanding
423.33M
No. of employees
2K
Open
CNยฅ44.47
High
CNยฅ44.71
Low
CNยฅ43.00
Mkt. cap
19.01B
Avg. vol.
11.11M
Volume
6.62M
Dividend
0.35%
Quarterly dividend
CNยฅ0.04
Ex-dividend date
Jun 9, 2026
P/E ratio
68.13
52-wk high
CNยฅ78.18
52-wk low
CNยฅ38.20
EPS
CNยฅ0.63
Shares outstanding
423.33M
No. of employees
2K
News stories
From web sources and news partners
About Betta Pharmaceuticals Co Ltd
CEO-
Employees1.78K
FoundedJan 7, 2003
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
892.00M
1.04B
936.09M
934.36M
Cost of goods sold
204.34M
217.50M
248.14M
256.72M
Cost of revenue
204.34M
217.50M
248.14M
256.72M
Research and development expenses
137.90M
97.44M
119.49M
106.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
477.36M
422.85M
465.85M
405.74M
Operating expense
625.07M
526.01M
606.92M
493.25M
Total operating expenses
829.41M
743.50M
855.05M
749.97M
Operating income
62.58M
296.33M
81.04M
184.38M
Other non operating income
6.81M
-10.30M
8.81M
-26.85M
EBT including unusual items
22.79M
282.47M
85.85M
10.80M
EBT excluding unusual items
38.51M
268.61M
54.28M
157.81M
Income tax expense
39.59M
51.31M
24.32M
35.92M
Effective tax rate
173.71%
18.16%
28.33%
332.66%
Other operating expenses
9.32M
6.34M
16.52M
-22.33M
Net income
-11.60M
235.92M
66.22M
-23.87M
Net profit margin
-1.30%
22.69%
7.07%
-2.56%
Earnings per share
-
-
-
-
Interest and investment income
369.02K
564.57K
445.21K
452.29K
Interest expense
-18.62M
-17.98M
-18.50M
-17.70M
Net interest expenses
-18.25M
-17.41M
-18.05M
-17.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
199.56M
433.31M
220.30M
321.36M
Gain or loss from assets sale
-377.65K
-
344.11K
-344.11K
Upcoming events
AI content may include mistakes. Learn more
Google apps